이바이오젠

R&D Project

Biotechnology research, R&D capabilities, and achievements

R&D Project 목록
No Project Title Program Name Development Details Project Period
13 Chungcheongnam-do RISE (Regional Innovation-Centered University Support System) Verified cockroach-related non-specific cross-reactivity and optimized the kit to reduce it. 2025.01. – 2025.12.
12 SME Technology Innovation Development Program (Market Response Type) Developed a 20-target rapid drug test and a high-sensitivity POCT reader. 2024.08. – 2026.07.
11 LINC 3.0 (Industry–University Cooperation) Developed domestic drug tests for single and multiplex detection, including novel drugs. 2024.06. – 2024.11.
10 Bio·Medical Technology Development Program Analyzed harmful components and evaluated vaping-related health risks to support policy. 2023.04. – 2027.12.
9 Infectious Disease Prevention & Treatment Technology Development Program Identified evaluation indicators and developed related diagnostic methods. 2023.04. – 2024.12.
8 2023 Emergency Technology Support Program Selected optimal antigen/antibody pairs and optimized the detection system. 2022.06. – 2023.12.
7 Technology Commercialization Support Program Developed a 15-minute immunoassay kit for easy home environmental checks. 2021.08. – 2022.01.
6 SME Technology Innovation Development Program (Market Response Type) Developed multiplex LFA drug tests and a portable automated analyzer for on-site use (e.g., saliva). 2020.07. – 2022.07.
5 - Developed a rapid test using highly specific antigen–antibody reactions. 2020.07. – 2020.12
4 Commercialization Development Project Developed a multiplex LFA strip for 4+ high-frequency drugs/toxicants. 2019.07. – 2019.12.
3 R&D Rediscovery Project Built MEF substrates, developed a microarrayer, and produced antibody chips and test kits. 2015.11. – 2017.11.
2 Industry–Academia Joint Technology Development Program Identified allergy-related markers via protein chips and developed analysis services. 2011.06. – 2012.05.
1 SME Technology Innovation Development Program Established an end-to-end protein-chip service system from fabrication to data analysis. 2008.12. – 2009.11.